| Novotný J, Pospěchová K, Hrabálek A, et al.
Synthesis of fluorescent C(24)-ceramide: Evidence for acyl chain length dependent differences in penetration of exogenous NBD-ceramides into human skin. [JOURNAL ARTICLE]
Bioorg Med Chem Lett 2009 Oct 15.
Abstract | Full Citation | Find Related Articles | | Diao JS, Xia WS, Guo SZ
Hearing improvement after bevacizumab for neurofibromatosis type 2. [Comment, Letter]
N Engl J Med 2009 Oct 29; 361(18):1810; author reply 1810-1.
Full Citation | Find Related Articles | | Buxant F, Engohan-Aloghe C, Noël JC
Estrogen Receptor, Progesterone Receptor, and Glucocorticoid Receptor Expression in Normal Breast Tissue, Breast In Situ Carcinoma, and Invasive Breast Cancer. [JOURNAL ARTICLE]
Appl Immunohistochem Mol Morphol 2009 Oct 28.
Abstract | Full Citation | | Garcia-Ac A, Segura PA, Viglino L, et al.
On-line solid-phase extraction of large-volume injections coupled to liquid chromatography-tandem mass spectrometry for the quantitation and confirmation of 14 selected trace organic contaminants in drinking and surface water. [JOURNAL ARTICLE]
J Chromatogr A 2009 Oct 12.
Abstract | Full Citation | | IL-2 immunotherapy does not benefit patients taking antiretrovirals. [News]
AIDS Patient Care STDS 2009 Mar; 23(3):221-2.
Full Citation | | Guntinas-Lichius O
Hearing improvement after bevacizumab for neurofibromatosis type 2. [Comment, Letter]
N Engl J Med 2009 Oct 29; 361(18):1809-10; author reply 1810-1.
Full Citation | Find Related Articles | | Hsu CS, Kao JH
Peginterferon alfa-2b or alfa-2a with ribavirin for hepatitis C. [Comment, Letter]
N Engl J Med 2009 Oct 29; 361(18):1808-9; author reply 1809.
Full Citation | Find Related Articles | | Henes J, Horger M, Kanz L, et al.
[56-year-old patient with leg paresis, pulmonary infiltrates, and eosinophilia--Case 08/2009] [Case Reports, English Abstract, Journal Article]
Dtsch Med Wochenschr 2009 Oct; 134(44):2228.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Ben Salem C, Hmouda H, Bouraoui K
Psoriasis. [Comment, Letter]
N Engl J Med 2009 Oct 22; 361(17):1710; author reply 1710.
Full Citation | Find Related Articles | | Perilongo G, Maibach R, Shafford E, et al.
Cisplatin versus cisplatin plus doxorubicin for standard-risk hepatoblastoma. [Comparative Study, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't]
N Engl J Med 2009 Oct 22; 361(17):1662-70.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |   |
|
| | Enter
www.unboundmedicine.com/medline
in your iPhone browser
or View our
Unbound MEDLINE
iPhone demo
Advertise on this site.
|
